SCHEMBL25980276

SCHEMBL25980276

c1ccc(-c2ccc(-c3nc(-c4ccc(-c5ccccc5)cc4)nc(-c4ccc5c(c4)oc4c(N(c6ccccc6)c6ccc(-c7ccccc7)cc6)cccc45)n3)cc2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.35
KMT2A Q03164 4/20 0.35
TSHR P16473 3/20 0.35
LMNA P02545 3/20 0.35
POLB P06746 2/20 0.35
HTT P42858 1/20 0.35
ALDH1A1 P00352 5/20 0.34
KDM4E B2RXH2 3/20 0.34
ABCG2 Q9UNQ0 2/20 0.34
HPGD P15428 4/20 0.33
PDE5A O76074 2/20 0.33
CYP1A2 P05177 2/20 0.33
CYP3A4 P08684 2/20 0.33
CYP2D6 P10635 2/20 0.33
CYP2C9 P11712 2/20 0.33
CYP2C19 P33261 2/20 0.33
GLA P06280 2/20 0.33
KDM1A O60341 1/20 0.33
RECQL P46063 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25979998 1.00 MAPT (0.35) MAPTKMT2ATSHRLMNAPOLB
SCHEMBL25980257 1.00 MAPT (0.35) MAPTKMT2ATSHRLMNAPOLB
SCHEMBL25980061 1.00 MAPT (0.35) MAPTKMT2ATSHRLMNAPOLB
SCHEMBL25980060 0.99 MAPT (0.35) MAPTKMT2ATSHRLMNAPOLB
SCHEMBL25980335 0.98 MAPT (0.38) MAPTKMT2ATSHRLMNAPOLB
SCHEMBL25980334 0.98 MAPT (0.34) MAPTKMT2ATSHRLMNAPOLB
SCHEMBL25980258 0.98 MAPT (0.34) MAPTKMT2ATSHRLMNAPOLB
SCHEMBL25980318 0.98 MAPT (0.35) MAPTKMT2ATSHRLMNAPOLB
SCHEMBL26779336 0.98 MAPT (0.35) MAPTKMT2ATSHRLMNAPOLB
SCHEMBL25979977 0.98 MAPT (0.36) MAPTKMT2ATSHRLMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
EP-4227301-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT Materials Co., Ltd. (KR) 2023-08-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 MAPT 1428/4885KMT2A 758/4885TSHR 4037/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.